Program
Amoxicillin
Also written as “amoxicillin”, “400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml” and “Amoxicillin Capsules”.
Its studies are mostly in Respiratory Tract Infections · Tonsillitis · Otitis Media · Sinusitis · Glossitis, Benign Migratory, led by 4 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKline | 40 open or running | phase 4since May 15, 2014 | Jul 18, 2006 | none ahead |
| Sun Pharmaceutical Industries | 30 open or running | no phasesince Oct 22, 2008 | Oct 22, 2008 | none ahead |
| Biocodex | 11 open or running | phase 4since Apr 23, 2024 | Apr 23, 2024 | Dec 2026phase 4 · NCT06451913 |
| deva-holding-a-s | 10 open or running | phase 3since May 12, 2010 | May 12, 2010 | none ahead |
Also a collaborator on its studies: pricara-unit-of-ortho-mcneil-inc.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 18, 2006First study: phase 1 study in Respiratory Tract InfectionsNew to GlaxoSmithKlineGlaxoSmithKline · NCT00354965 · 52 enrolled · United States
- Oct 22, 2008Sun Pharmaceutical Industries's first studies: 3 no phase studies in HealthyNew to Sun Pharmaceutical IndustriesSun Pharmaceutical Industries · NCT00778661, NCT00778284, NCT00778050
- May 12, 2010deva-holding-a-s's first study: phase 3 study in Helicobacter Pylori InfectionNew to deva-holding-a-sdeva-holding-a-s · NCT01131026 · 60 enrolled · Turkey
- Sep 8, 2011Phase 1 study in Bacterial InfectionsGlaxoSmithKline · NCT01431989 · 28 enrolled · Brazil
- Jan 17, 2013Phase 1 study in Respiratory Tract InfectionsGlaxoSmithKline · NCT01772238 · 35 enrolled
- May 15, 2014Phase 4 study in Focal Infection, DentalGlaxoSmithKline · NCT02141217 · 472 enrolled · Malaysia, Philippines, Thailand and more
- Apr 23, 2024Biocodex's first study: phase 4 study in Erythema Chronicum MigransNew to BiocodexBiocodex · NCT06451913 · 120 planned · Slovenia
Ahead
- Dec 2026Primary completion: phase 4 study in Erythema Chronicum MigransBiocodex · NCT06451913
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“Bacterial penicillin-binding protein inhibitor”ChEMBL 37, by rule
Studies
All 9 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06451913Erythema Chronicum Migrans · Slovenia | 4 | Recruiting | Biocodex | Dec 2026 | 120 |
| NCT02141217Focal Infection, Dental · Malaysia, Philippines, Thailand and more | 4 | Completed | GlaxoSmithKline | Dec 28, 2013 | 472 |
| NCT01772238Respiratory Tract Infections | 1 | Completed | GlaxoSmithKline | Mar 30, 2011 | 35 |
| NCT01431989Bacterial Infections · Brazil | 1 | Completed | GlaxoSmithKline | Jun 11, 2011 | 28 |
| NCT01131026Helicobacter Pylori Infection · Turkey | 3 | Completed | deva-holding-a-s | Aug 2011 | 60 |
| NCT00778661Healthy · United States | – | Completed | Sun Pharmaceutical Industries | Oct 2002 | 40 |
| NCT00778284Healthy · United States | – | Completed | Sun Pharmaceutical Industries | Oct 2002 | 40 |
| NCT00778050Healthy · United States | – | Completed | Sun Pharmaceutical Industries | Oct 2002 | 26 |
| NCT00354965Respiratory Tract Infections · United States | 1 | Completed | GlaxoSmithKline | Apr 2, 2007 | 52 |
How it is read
Names in the registry
- “Amoxicillin”, 6 entries
- “amoxicillin”, 4 entries
- “400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml”, 2 entries
- “Amoxicillin Capsules”, 1 entry
- “Amoxicillin + Saccharomyces boulardii CNCM I-745”, 1 entry
Conditions, from the studies’ own filings
- Respiratory Tract Infections, 2 studies
- Tonsillitis, 2 studies
- Otitis Media, 2 studies
- Sinusitis, 2 studies
- Glossitis, Benign Migratory, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.